Document Detail

Mortality associated with delays between clinic entry and ART initiation in resource-limited settings: results of a transition-state model.
MedLine Citation:
PMID:  23392457     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To estimate the mortality impact of delay in antiretroviral therapy (ART) initiation from the time of entry into care.
DESIGN: A state-transition Markov process model. This technique allows for assessing mortality before and after ART initiation associated with delays in ART initiation among a general population of ART-eligible patients without conducting a randomized trial.
METHODS: We used patient-level data from 3 South African cohorts to determine transition probabilities for pre-ART CD4 count changes and pre-ART and on-ART mortality. For each parameter, we generated probabilities and distributions for Monte Carlo simulations with 1-week cycles to estimate mortality 52 weeks from clinic entry.
RESULTS: We estimated an increase in mortality from 11.0% to 14.7% (relative increase of 34%) with a 10-week delay in ART for patients entering care with our pre-ART cohort CD4 distribution. When we examined low CD4 ranges, the relative increase in mortality delays remained similar; however, the absolute increase in mortality rose. For example, among patients entering with CD4 count 50-99 cells per cubic millimeter, 12-month mortality increased from 13.3% with no delay compared with 17.0% with a 10-week delay and 22.9% with a 6-month delay.
CONCLUSIONS: Delays in ART initiation, common in routine HIV programs, can lead to important increases in mortality. Prompt ART initiation for patients entering clinical care and eligible for ART, especially those with lower CD4 counts, could be a relatively low-cost approach with a potential marked impact on mortality.
Christopher J Hoffmann; James J Lewis; David W Dowdy; Katherine L Fielding; Alison D Grant; Neil A Martinson; Gavin J Churchyard; Richard E Chaisson
Related Documents :
1414517 - Results of continuous long-term intravenous application of octreotide via an implantabl...
218997 - Predicting the response of growth hormone-deficient children to long term treatment wit...
16195777 - Outcome of surgery for acromegaly performed by different surgeons: importance of surgic...
15762187 - Long-term maintenance of the anabolic effects of gh on the skeleton in successfully tre...
25142557 - White matter integrity in obstructive sleep apnea before and after treatment.
25441247 - Randomized, double-blinded, clinical trial of propofol, 1:1 propofol/ketamine, and 4:1 ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of acquired immune deficiency syndromes (1999)     Volume:  63     ISSN:  1944-7884     ISO Abbreviation:  J. Acquir. Immune Defic. Syndr.     Publication Date:  2013 May 
Date Detail:
Created Date:  2013-04-11     Completed Date:  2013-06-24     Revised Date:  2014-05-07    
Medline Journal Info:
Nlm Unique ID:  100892005     Medline TA:  J Acquir Immune Defic Syndr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  105-11     Citation Subset:  IM; X    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Ambulatory Care Facilities / statistics & numerical data*
Anti-HIV Agents / administration & dosage,  therapeutic use*
CD4 Lymphocyte Count
HIV Infections / drug therapy,  mortality*
Monte Carlo Method*
South Africa / epidemiology
Survival Analysis
Survival Rate
Time Factors
Grant Support
Reg. No./Substance:
0/Anti-HIV Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mitochondrial haplogroups are associated with clinical pattern of AIDS progression in human immunode...
Next Document:  Dynamics of CD8 T-Cell Activation after Discontinuation of HIV Treatment Intensification.